The Trump administration has expressed interest in aligning the U.S. childhood vaccination schedule with that of Denmark, which recommends fewer vaccines for children. Critics argue that the U.S. faces different health threats that necessitate a more comprehensive vaccination approach.

In 2025, NPR's Goats and Soda highlighted significant global health and development stories, including the emotional impact of changes in U.S. foreign aid, unexpected findings related to common diseases, and stunning visuals of the planet captured by drone technology.

Scientists have developed an experimental method to study the implantation of human embryos in a uterus using artificial wombs, which could enhance understanding of the implantation process. This research aims to provide insights into the causes of miscarriages and potential preventive measures.

States are tightening their budgets in response to nearly $1 trillion in anticipated federal Medicaid cuts, leading to reduced funding for a widely accepted autism therapy that many families rely on. This decision has raised concerns among parents and advocates who fear the impact on access to essential services for children with autism.

U.S. regulators have approved Wegovy in pill form, marking a significant advancement as it becomes the first daily oral medication for weight loss, developed by Novo Nordisk. This approval is seen as a pivotal moment in the treatment of obesity, providing a new option for patients seeking effective weight management solutions.

Researchers are investigating why GLP-1 weight loss drugs, which have significantly changed obesity treatment, do not yield substantial weight loss for all users. Understanding these discrepancies is crucial for enhancing the effectiveness of these medications.

The proportion of individuals with severe mental illness in state psychiatric hospitals who are accused of serious crimes has significantly increased, leading to a near-complete cessation of opportunities for preventative care before crises occur.

Some patients are encountering significant obstacles in accessing HIV prevention drugs, particularly daily preventive pills, due to a lack of knowledge among some healthcare providers about prescribing these medications and common billing issues.

Researchers are investigating why GLP-1 weight loss drugs, which have significantly changed obesity treatment, do not yield substantial weight loss for all users. Understanding these discrepancies is crucial for optimizing treatment effectiveness.